Helicobacter Eradication Aspirin Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

30,024

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2017

Study Completion Date

March 16, 2022

Conditions
Gastrointestinal Ulcer HaemorrhageBacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions
DRUG

Lansoprazole 30mg, Clarithromycin 500mg, Metronidazole 400mg

All three medications will be taken orally, twice daily, for seven days.

DRUG

Placebo lansoprazole 30mg, clarithromycin 500mg, metronidazole 400mg

Medication to be taken orally, twice a day, for seven days.

Trial Locations (6)

BT9 7HR

Queen's University, Belfast

B15 2TT

University of Birmingham, Birmingham

TS17 6BH

Durham University, Durham

NG7 2UH

University of Nottingham, Nottingham

OX1 2ET

University of Oxford, Oxford

SO16 5ST

University of Southampton, Southampton

All Listed Sponsors
collaborator

Nottingham University Hospitals NHS Trust

OTHER

collaborator

University of Southampton

OTHER

collaborator

University of Durham

OTHER

collaborator

University of Birmingham

OTHER

collaborator

University of Oxford

OTHER

collaborator

Queen's University, Belfast

OTHER

lead

University of Nottingham

OTHER

NCT01506986 - Helicobacter Eradication Aspirin Trial | Biotech Hunter | Biotech Hunter